M28 Capital Management LP
Annual return '25
+17.6%
SPY '25
+17.7%
Alpha
-0.2ptsvs SPY
Invested
$53.8M
Holdings
9
Trades YTD
0
Performance · Fund vs SPY
Cumulative return · quarterly snapshotsCoverage 100%. 4 quarters of 2025 measured against SPY adj-close benchmark.
Top holdings · current snapshot
Source: 13F-HR01
$WVE
WAVE LIFE SCIENCES LTD
Q1 2026: Exited (was 5.66M shares)
61.8%
02
$IVVD
INVIVYD INC
Q1 2026: Exited (was 9.25M shares)
22.3%
03
$TGTX
TG THERAPEUTICS INC
Q1 2026: Exited (was 161.6k shares)
5.5%
04
$ARWR
ARROWHEAD PHARMACEUTICALS IN
Q1 2026: Exited (was 67.4k shares)
4.3%
05
$PRQR
PROQR THRAPEUTICS N V
Q1 2026: Exited (was 1.02M shares)
1.8%
06
$GUTS
FRACTYL HEALTH INC
Q1 2026: Exited (was 1.86M shares)
1.6%
07
$RCKT
ROCKET PHARMACEUTICALS INC
Q1 2026: Exited (was 385.7k shares)
1.4%
08
$SLN
SILENCE THERAPEUTICS PLC
Q1 2026: Exited (was 185.1k shares)
1.0%
09
$CRIS
CURIS INC
Q1 2026: Exited (was 521.1k shares)
0.3%
Recent trades · Last 90 days
No Form 4 / 13D / 13G trade events on file in the recent window. 13F filers report position snapshots quarterly rather than per-trade events, so this section is most useful for managers who also file Form 4 or 13D/G.
Convergence · Pattern Engine ships in v1.1
30-day windowIn development
Convergence participation lands with the Pattern Engine.
Once the Pattern Engine ships, this section will list every active convergence event this fund is named in — with the other named funds, the Congress members on the same name, and combined position size.
Source data: SEC EDGAR · 13F-HR filings · Performance through 2025-12-31 · Last refreshed 13:24 UTC.